Insights

Strategic Collaboration MTM operates as a collaborative, entrepreneur-led ecosystem builder, presenting a sales opportunity to partner on co-development and acceleration programs for early-stage biotech ventures.

Inflammation Focus Recent partnership with UniQuest to form a startup aimed at anti-inflammatory medicines highlights a growing market segment and potential for MTM to provide platform capabilities, validation, and co-discovery services to inflammation-focused programs.

Global Ecosystem MTM’s global network and agile operations suggest readiness to scale and support international ventures, offering market access, regulatory navigation support, and cross-border collaboration propositions.

Tech Enablement Utilization of cloud, web, and deployment technologies (AWS, HTTP/3, Cloudflare, Webflow) indicates a capability to deliver scalable digital workflows and data-centric R&D services that can be offered as managed platforms or integration partnerships.

Financial & Growth Signals Revenue range positions MTM as a lean growth-focused partner with potential for tiered collaboration models (co-development, milestone-based funding, and sponsored research) with medium-sized biotech stakeholders seeking nimble execution.

Similar companies to Molecule to Medicine

Molecule to Medicine Tech Stack

Molecule to Medicine uses 8 technology products and services including html5media, Amazon Web Services, gstatic.com, and more. Explore Molecule to Medicine's tech stack below.

  • html5media
    Audio, Video, Graphics
  • Cloud Hosting
  • gstatic.com
    Content Delivery Network
  • jQuery
    Javascript Libraries
  • Page Builders
  • Cloudflare Bot Management
    Security
  • HSTS
    Security
  • HTTP/3
    Web & Portal Technology

Molecule to Medicine's Email Address Formats

Molecule to Medicine uses at least 2 email formats:
Molecule to Medicine Email FormatsExamplePercentage
First@molecule2medicine.comJohn@molecule2medicine.com
87%
First.Last@molecule2medicine.comJohn.Doe@molecule2medicine.com
13%

Frequently Asked Questions

What is Molecule to Medicine's official website and social media links?

Minus sign iconPlus sign icon
Molecule to Medicine's official website is moleculetomedicine.com and has social profiles on LinkedIn.

How much revenue does Molecule to Medicine generate?

Minus sign iconPlus sign icon
As of August 2026, Molecule to Medicine's annual revenue is estimated to be $1M - $10M.

What is Molecule to Medicine's SIC code and NAICS code?

Minus sign iconPlus sign icon
Molecule to Medicine's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Molecule to Medicine have currently?

Minus sign iconPlus sign icon
As of August 2026, Molecule to Medicine has approximately 39 employees across 4 continents, including Europe, North America and Oceania. Key team members include Chief Executive Officer: K. M., Chief Operating Officer: S. H. and Chief Financial Officer: L. S. Explore Molecule to Medicine's employee directory with LeadIQ.

What industry does Molecule to Medicine belong to?

Minus sign iconPlus sign icon
Molecule to Medicine operates in the Biotechnology Research industry.

What technology does Molecule to Medicine use?

Minus sign iconPlus sign icon
Molecule to Medicine's tech stack includes html5media, Amazon Web Services, gstatic.com, jQuery, Webflow, Cloudflare Bot Management, HSTS and HTTP/3.

What is Molecule to Medicine's email format?

Minus sign iconPlus sign icon
Molecule to Medicine's email format typically follows the pattern of First@molecule2medicine.com. Find more Molecule to Medicine email formats with LeadIQ.

When was Molecule to Medicine founded?

Minus sign iconPlus sign icon
Molecule to Medicine was founded in 2015.
Molecule to Medicine logo

Molecule to Medicine

Biotechnology ResearchEngland, United Kingdom11-50 Employees

Molecule to Medicine MTM operates in biotechnology research as a global platform that supports collaborative venture creation. Run by entrepreneurs for entrepreneurs, MTM helps scientists and founders co-create and scale new companies within its international ecosystem. By blending established drug-discovery capabilities with agile operations, the organization aims to accelerate breakthroughs and move potential medicines forward. 
MTM is based in Milton, Oxfordshire, England, and positions itself within the biotechnology research sector as a facilitator of early-stage ventures seeking to translate discoveries into medicines. A concrete recent development is a partnership with UniQuest, the University of Queensland's commercialisation arm, which led to the formation of a new startup focused on discovering and developing anti-inflammatory medicines.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
11-50

Section iconFunding & Financials

  • $1M - $10M

    Molecule to Medicine's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.